Omnicell Return on Tangible Equity 2010-2025 | OMCL

Current and historical return on tangible equity values for Omnicell (OMCL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Omnicell Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.02B $0.34B 7.17%
2024-12-31 $0.01B $0.32B 4.58%
2024-09-30 $-0.02B $0.30B -6.43%
2024-06-30 $-0.02B $0.27B -8.06%
2024-03-31 $-0.02B $0.25B -9.08%
2023-12-31 $-0.02B $0.24B -9.41%
2023-09-30 $-0.03B $0.23B -17.87%
2023-06-30 $-0.02B $0.20B -13.53%
2023-03-31 $-0.02B $0.17B -11.79%
2022-12-31 $0.01B $0.15B 5.12%
2022-09-30 $0.05B $0.15B 43.05%
2022-06-30 $0.06B $0.10B 42.18%
2022-03-31 $0.07B $0.07B 32.68%
2021-12-31 $0.08B $0.13B 26.69%
2021-09-30 $0.08B $0.28B 23.87%
2021-06-30 $0.06B $0.40B 15.55%
2021-03-31 $0.04B $0.35B 8.99%
2020-12-31 $0.03B $0.30B 7.85%
2020-09-30 $0.04B $0.47B 8.86%
2020-06-30 $0.05B $0.44B 12.33%
2020-03-31 $0.07B $0.42B 18.97%
2019-12-31 $0.06B $0.38B 18.97%
2019-09-30 $0.05B $0.34B 19.60%
2019-06-30 $0.05B $0.30B 21.55%
2019-03-31 $0.04B $0.26B 22.81%
2018-12-31 $0.04B $0.20B 31.08%
2018-09-30 $0.06B $0.13B 62.86%
2018-06-30 $0.05B $0.10B 108.89%
2018-03-31 $0.04B $0.07B 880.00%
2017-12-31 $0.03B $0.05B -98.41%
2017-09-30 $0.01B $-0.04B -13.85%
2017-06-30 $0.00B $-0.06B -4.08%
2017-03-31 $0.00B $-0.07B 0.00%
2016-12-31 $0.01B $-0.09B -11.14%
2016-09-30 $0.01B $-0.07B -33.33%
2016-06-30 $0.02B $-0.09B 52.63%
2016-03-31 $0.03B $-0.11B 27.55%
2015-12-31 $0.03B $0.17B 18.42%
2015-09-30 $0.03B $0.15B 18.47%
2015-06-30 $0.03B $0.16B 17.37%
2015-03-31 $0.03B $0.20B 16.09%
2014-12-31 $0.03B $0.19B 16.74%
2014-09-30 $0.03B $0.17B 16.28%
2014-06-30 $0.03B $0.19B 17.06%
2014-03-31 $0.03B $0.17B 17.09%
2013-12-31 $0.02B $0.16B 16.41%
2013-09-30 $0.02B $0.16B 17.04%
2013-06-30 $0.02B $0.14B 18.57%
2013-03-31 $0.02B $0.13B 16.11%
2012-12-31 $0.02B $0.11B 11.55%
2012-09-30 $0.01B $0.10B 8.08%
2012-06-30 $0.01B $0.09B 4.76%
2012-03-31 $0.01B $0.26B 4.84%
2011-12-31 $0.01B $0.25B 4.55%
2011-09-30 $0.01B $0.25B 3.37%
2011-06-30 $0.01B $0.24B 2.58%
2011-03-31 $0.01B $0.23B 2.17%
2010-12-31 $0.01B $0.23B 2.20%
2010-09-30 $0.01B $0.23B 2.24%
2010-06-30 $0.01B $0.23B 2.28%
2010-03-31 $0.00B $0.22B 1.86%
2009-12-31 $0.00B $0.21B 0.48%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.429B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.994B 58.52
Hims & Hers Health (HIMS) United States $12.427B 102.82
Doximity (DOCS) United States $10.881B 50.37
Tempus AI (TEM) United States $9.996B 0.00
IRhythm Technologies (IRTC) United States $5.151B 0.00
Hinge Health (HNGE) United States $3.762B 0.00
Inspire Medical Systems (INSP) United States $2.600B 38.22
Privia Health (PRVA) United States $2.371B 162.08
10x Genomics (TXG) United States $1.639B 0.00
Phreesia (PHR) United States $1.613B 0.00
Enovis (ENOV) United States $1.511B 8.43
Clover Health Investments (CLOV) United States $1.450B 0.00
Schrodinger (SDGR) United States $1.441B 0.00
Azenta (AZTA) United States $1.231B 53.80
Evolent Health (EVH) United States $1.115B 95.00
Claritev (CTEV) United States $0.650B 0.00
Fulgent Genetics (FLGT) United States $0.636B 0.00
Veradigm (MDRX) United States $0.514B 0.00
Standard BioTools (LAB) United States $0.494B 0.00
Talkspace (TALK) United States $0.380B 113.50
Zepp Health (ZEPP) Netherlands $0.349B 0.00
Butterfly Network (BFLY) United States $0.336B 0.00
Carlsmed (CARL) $0.325B 0.00
TruBridge (TBRG) United States $0.314B 696.33
Health Catalyst (HCAT) United States $0.266B 0.00
Nyxoah SA (NYXH) Belgium $0.254B 0.00
Outset Medical (OM) United States $0.250B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.228B 0.00
CapsoVision (CV) United States $0.192B 0.00
KORU Medical Systems (KRMD) United States $0.151B 0.00
American Well (AMWL) United States $0.132B 0.00
MDxHealth SA (MDXH) Belgium $0.118B 0.00
EUDA Health Holdings (EUDA) Singapore $0.113B 0.00
CareCloud (CCLD) United States $0.101B 4.58
ImmunoPrecise Antibodies (IPA) Canada $0.084B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.075B 0.00
Pulmonx (LUNG) United States $0.067B 0.00
111 (YI) China $0.059B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.034B 0.00
Zhongchao (ZCMD) China $0.024B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.013B 0.00
HeartSciences (HSCS) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.007B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.005B 0.00
Movano (MOVE) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
PROFUSA (PFSA) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00